ATE494374T1 - Ingap-protein und dessen beteiligung an der neogenese pankreatischer inselzellen - Google Patents
Ingap-protein und dessen beteiligung an der neogenese pankreatischer inselzellenInfo
- Publication number
- ATE494374T1 ATE494374T1 AT96905368T AT96905368T ATE494374T1 AT E494374 T1 ATE494374 T1 AT E494374T1 AT 96905368 T AT96905368 T AT 96905368T AT 96905368 T AT96905368 T AT 96905368T AT E494374 T1 ATE494374 T1 AT E494374T1
- Authority
- AT
- Austria
- Prior art keywords
- participation
- cdna
- cell neogenesis
- identified
- ingap
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/474—Pancreatic thread protein; Reg protein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4733—Acute pancreatitis-associated protein
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/401,530 US5834590A (en) | 1995-02-22 | 1995-02-22 | Ingap protein involved in pancreatic islet neogenesis |
US627195P | 1995-11-07 | 1995-11-07 | |
PCT/US1996/001528 WO1996026215A1 (en) | 1995-02-22 | 1996-02-12 | Ingap protein involved in pancreatic islet neogenesis |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE494374T1 true ATE494374T1 (de) | 2011-01-15 |
Family
ID=26675411
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT96905368T ATE494374T1 (de) | 1995-02-22 | 1996-02-12 | Ingap-protein und dessen beteiligung an der neogenese pankreatischer inselzellen |
Country Status (6)
Country | Link |
---|---|
US (2) | US5840531A (de) |
EP (1) | EP0815129B1 (de) |
JP (2) | JP4111539B2 (de) |
AT (1) | ATE494374T1 (de) |
CA (1) | CA2213610C (de) |
DE (1) | DE69638315D1 (de) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6265165B1 (en) * | 1998-11-12 | 2001-07-24 | The Regents Of The University Of California | Methods for EST-specific full length cDNA cloning |
US6986994B2 (en) * | 2001-01-09 | 2006-01-17 | Gmp Endotherapeutics, Inc. | INGAP displacement assays |
WO2002070551A2 (en) * | 2001-03-01 | 2002-09-12 | Mcgill University | Neuritogenic compound and uses thereof |
US6642003B2 (en) | 2001-08-02 | 2003-11-04 | Cedars-Sinai Medical Center | Human glucose-dependent insulin-secreting cell line |
US20040132644A1 (en) * | 2001-10-16 | 2004-07-08 | The Procter & Gamble Company | Composition and method for treating diabetes |
US7355024B2 (en) * | 2002-01-11 | 2008-04-08 | Gmp Endotherapeutics, Inc. | Regulatory sequences for modulation of INGAP expression and reporter constructs |
US7662768B2 (en) * | 2002-01-11 | 2010-02-16 | Mcgill University | Transdifferentiation of pancreatic acinar cells |
US7166439B2 (en) * | 2002-03-01 | 2007-01-23 | Gmp Endotherapeutics, Inc. | Assay for anti-INGAP antibodies |
US7141240B2 (en) * | 2002-03-12 | 2006-11-28 | Cedars-Sinai Medical Center | Glucose-dependent insulin-secreting cells transfected with a nucleotide sequence encoding GLP-1 |
JP2008531730A (ja) * | 2005-03-04 | 2008-08-14 | キュアーディーエム、インク. | I型真性糖尿病及び他の症状を治療するための方法及び薬学的組成物 |
US20090142338A1 (en) * | 2005-03-04 | 2009-06-04 | Curedm, Inc. | Methods and Compositions for Treating Type 1 and Type 2 Diabetes Mellitus and Related Conditions |
US7393919B2 (en) * | 2005-05-25 | 2008-07-01 | Cure Dm, Inc. | Peptides, derivatives and analogs thereof, and methods of using same |
WO2008064306A2 (en) * | 2006-11-22 | 2008-05-29 | Curedm, Inc. | Methods and compositions relating to islet cell neogenesis |
NZ599756A (en) * | 2007-08-30 | 2013-09-27 | Curedm Group Holdings Llc | Compositions and methods of using proislet peptides and analogs thereof |
US8012928B2 (en) * | 2008-12-19 | 2011-09-06 | The Research Foundation Of State University Of New York | Truncated PAP2 and methods of making and using same |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4965188A (en) * | 1986-08-22 | 1990-10-23 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme |
FR2700011B1 (fr) * | 1992-12-24 | 1995-02-24 | Inst Nat Sante Rech Med | Détection de la mucoviscidose ou d'une mutation du gêne CFTR au moyen d'un dosage de la PAP. |
US5834590A (en) * | 1995-02-22 | 1998-11-10 | Eastern Virginia Medical School Of The Medical College Of Hampton Roads | Ingap protein involved in pancreatic islet neogenesis |
-
1996
- 1996-02-12 CA CA2213610A patent/CA2213610C/en not_active Expired - Lifetime
- 1996-02-12 AT AT96905368T patent/ATE494374T1/de not_active IP Right Cessation
- 1996-02-12 JP JP52570296A patent/JP4111539B2/ja not_active Expired - Fee Related
- 1996-02-12 DE DE69638315T patent/DE69638315D1/de not_active Expired - Lifetime
- 1996-02-12 EP EP96905368A patent/EP0815129B1/de not_active Expired - Lifetime
- 1996-09-09 US US08/709,662 patent/US5840531A/en not_active Expired - Lifetime
-
2000
- 2000-11-22 US US09/717,095 patent/USRE39062E1/en not_active Expired - Lifetime
-
2007
- 2007-05-09 JP JP2007124746A patent/JP2007291114A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2007291114A (ja) | 2007-11-08 |
JP4111539B2 (ja) | 2008-07-02 |
JPH11500907A (ja) | 1999-01-26 |
MX9706418A (es) | 1998-07-31 |
CA2213610A1 (en) | 1996-08-29 |
EP0815129A4 (de) | 2000-08-16 |
EP0815129B1 (de) | 2011-01-05 |
CA2213610C (en) | 2013-12-03 |
EP0815129A1 (de) | 1998-01-07 |
AU708499B2 (en) | 1999-08-05 |
AU4914996A (en) | 1996-09-11 |
USRE39062E1 (en) | 2006-04-11 |
US5840531A (en) | 1998-11-24 |
DE69638315D1 (de) | 2011-02-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE494374T1 (de) | Ingap-protein und dessen beteiligung an der neogenese pankreatischer inselzellen | |
AU2078599A (en) | Self-expanding bifurcation stent and delivery system | |
AU6824994A (en) | An intraluminal stent graft | |
DE69900689D1 (en) | Topoisomerase inhibitoren zur restenose-prevention | |
AU5776696A (en) | Bifurcated endovascular stent | |
DE69426946T2 (de) | Brennstoffsteuerungssystem für stufenbrenner | |
DK0868505T3 (da) | Chondrogen in vitro induktion af humane mesenchymstamceller | |
AU1085800A (en) | Bifurcation stent and delivery systems | |
HUP9901058A3 (en) | An expandable endovascular stent | |
AU1052597A (en) | Ostial stent balloon | |
MX9709716A (es) | Metodos para incorporar substancias estables dentro de matrices de vidrio celular secas y composiciones obtenidas mediante los mismos. | |
DE69527899T2 (de) | Herstellungsmethode für einen intraluminalen Stent | |
EP1275548A3 (de) | Leitungssystem zur Zuführung von gasförmigem Brennstoff | |
DE69116550D1 (de) | Steroid-sulfatase-inhibitoren | |
DK0687294T3 (da) | Epitelcellelinier afledt af human lever | |
DE69630955D1 (de) | Immortalisierung bzw. desimmortalisierung von zellen | |
ATE314477T1 (de) | An der streptogramin biosynthese beteiligte polypeptide, ihre kodierenden nukleotidsequenzen und ihre verwendung | |
FI854910A0 (fi) | Anordning foer distortionsfri utstrykning av display under en enskild bild. | |
HUP9801438A3 (en) | Recombinant preduodenal lipases and polypeptide derivatives produced by plants, processes for obtaining them and their uses | |
DK0827505T3 (da) | Udvalgte opløselige estere af hydroxylholdige indolocarbazoler | |
DE69412848D1 (de) | Arbeitskammer für toxische umweltbedingungen | |
AU4311197A (en) | Culture system for hematopoietic stem cells | |
AU9649898A (en) | Method for regulating the differentiation/proliferation of hematopoietic stem cells | |
WO1998029566A3 (en) | Novel method for testing the differentiation status in pancreatic cells of a mammal | |
NO985079L (no) | Eksplosiv formulering |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |